Xspray Pharma AB (publ)

Stockholm Stock Exchange XSPRAY.ST

Xspray Pharma AB (publ) Inventory for the year ending December 31, 2023: USD 4.32 M

Xspray Pharma AB (publ) Inventory is USD 4.32 M for the year ending December 31, 2023, a 429.09% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Xspray Pharma AB (publ) Inventory for the year ending December 31, 2022 was USD 816.72 K, a 19.66% change year over year.
Xspray Pharma AB (publ) Inventory for the year ending December 31, 2021 was USD 682.51 K, a 0.00% change year over year.
Xspray Pharma AB (publ) Inventory for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
Xspray Pharma AB (publ) Inventory for the year ending December 31, 2019 was USD 0.00, a 100.00% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

Stockholm Stock Exchange: XSPRAY.ST

Xspray Pharma AB (publ)

CEO	Dr. Per Andersson Ph.D.
IPO Date	Sept. 28, 2017
Location	Sweden
Headquarters	Råsundavägen 12
Employees	24
Sector	Healthcare
Industries Biotechnology Clinical Trials Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Pharmaceuticals

Description

Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo for the treatment of chronic myeloid leukemia; HyNap-Sora for the treatment of renal cancer and liver cancer, as well as several forms of thyroid cancer; and HyNap-Dasa for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is based in Solna, Sweden.

Key trends

Past 5 years